Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government
Veterans Benefits and Health Care About VA Find a VA Location

VA Health Systems Research

Go to the VA ORD website
Go to the QUERI website

Citations Database Search Results

Download these results to MS Excel

46 records found for:
Author = Doll J
Year =

  1. Salahuddin T, Hebbe A, Daus M, Essien UR, Waldo SW, Rodriguez F, Ho PM, Simons C, Gilmartin HM, Doll JA. Trends and Site-level Variation of Novel Cardiovascular Medication Utilization among Patients Admitted for Heart Failure or Coronary Artery Disease in the US Veterans Affairs System: 2017-2021. American heart journal. 2023 Nov 11; 10.1016/j.ahj.2023.11.009.
  2. Abera SM, O'Donnell C, Salahuddin T, Prabhu K, Simons CE, Ho PM, Waldo SW, Doll JA. Assessment of Medication Adherence Using Pharmacy Data Before and After Percutaneous Coronary Intervention. Patient preference and adherence. 2023 Nov 3; 17:2789-2795.
  3. Naranjo D, Doll J, Maynard C, Beaver K, Bansal A, Helfrich CD. Practice Pattern Variation in Adoption of New and Evolving Percutaneous Coronary Intervention Procedures. Journal of interventional cardiology. 2023 May 4; 2023:2488045.
  4. Blankenship JC, Doll JA, Latif F, Truesdell AG, Young MN, Ibebuogu UN, Vallabhajosyula S, Kadavath SM, Maestas CM, Vetrovec G, Welt F. Best Practices for Cardiac Catheterization Laboratory Morbidity and Mortality Conferences. JACC. Cardiovascular interventions. 2023 Mar 13; 16(5):503-514.
  5. Kataruka A, Maynard CC, Hira RS, Dean L, Dardas T, Gurm H, Brown J, Ring ME, Doll JA. Government Regulation and Percutaneous Coronary Intervention Volume, Access and Outcomes: Insights From the Washington State Cardiac Care Outcomes Assessment Program. Journal of the American Heart Association. 2022 Sep 6; 11(17):e025607.
  6. Thai T, Louden DKN, Adamson R, Dominitz JA, Doll JA. Peer evaluation and feedback for invasive medical procedures: a systematic review. BMC medical education. 2022 Jul 29; 22(1):581.
  7. Doll JA, Lata K, Kearney KE. Feedback and the Early Career Proceduralist: How Am I Doing? Journal of the American College of Cardiology. 2022 Mar 29; 79(12):1215-1219.
  8. Doll JA, Beaver K, Naranjo D, Waldo SW, Maynard C, Helfrich CD, Rao SV. Trends in Arterial Access Site Selection and Bleeding Outcomes Following Coronary Procedures, 2011-2018. Circulation. Cardiovascular quality and outcomes. 2022 May 1; 15(5):e008359.
  9. Waldo SW, Glorioso TJ, Barón AE, Doll JA, Plomondon ME, Ho PM. Transitions of Care Among Patients Undergoing Percutaneous Coronary Intervention for Stable Angina: Insights From the Veterans Affairs Clinical Assessment Reporting and Tracking Program. Journal of the American Heart Association. 2022 Feb 15; 11(4):e024598.
  10. Doll JA, Nelson AJ, Kaltenbach LA, Wojdyla D, Waldo SW, Rao SV, Wang TY. Percutaneous Coronary Intervention Operator Profiles and Associations With In-Hospital Mortality. Circulation. Cardiovascular interventions. 2022 Jan 1; 15(1):e010909.
  11. Doll JA, O'Donnell CI, Plomondon ME, Waldo SW. Contemporary Clinical and Coronary Anatomic Risk Model for 30-Day Mortality After Percutaneous Coronary Intervention. Circulation. Cardiovascular interventions. 2021 Dec 1; 14(12):e010863.
  12. Kovach CP, O'Donnell CI, Swat S, Doll JA, Plomondon ME, Schofield R, Valle JA, Waldo SW. Impact of Operator Volumes and Experience on Outcomes After Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting and Tracking (CART) Program. Cardiovascular revascularization medicine : including molecular interventions. 2022 Jul 1; 40:64-68.
  13. Gilmartin HM, Plomondon ME, Mueller C, Connelly B, Battaglia C, Waldo SW, Doll J. The Impacts of COVID-19 on Veterans Affairs Catheterization Laboratory Staff During the First Months of the US Response. The Journal of cardiovascular nursing. 2021 Nov 1; 36(6):595-598.
  14. Beaver K, Naranjo D, Doll J, Maynard C, Taylor L, Plomondon M, Waldo S, Helfrich CD, Rao SV. Design and baseline results of a coaching intervention for implementation of trans-radial access in percutaneous coronary intervention. Contemporary clinical trials. 2021 Dec 1; 111:106606.
  15. Kochar A, Doll JA, Liang L, Curran J, Peterson ED. Temporal Trends in Post Myocardial Infarction Heart Failure and Outcomes Among Older Adults. Journal of cardiac failure. 2022 Apr 1; 28(4):531-539.
  16. Nguyen DD, Doll JA. Quality Improvement and Public Reporting in STEMI Care. Interventional cardiology clinics. 2021 Jul 1; 10(3):391-400.
  17. Prabhu KM, Don C, Sayre GG, Kearney KE, Hira RS, Waldo SW, Rao SV, Au DH, Doll JA. Interventional cardiologists' perceptions of percutaneous coronary intervention quality measurement and feedback. American heart journal. 2021 May 1; 235:97-103.
  18. Waldo SW, Hebbe A, Grunwald GK, Doll JA, Schofield R. Clinical and Anatomic Complexity of Patients Undergoing Coronary Intervention With and Without On-Site Surgical Capabilities: Insights From the Veterans Affairs Clinical Assessment, Reporting and Tracking (CART) Program. Circulation. Cardiovascular interventions. 2021 Jan 1; 14(1):e009697.
  19. Nathan AS, Raman S, Yang N, Painter I, Khatana SAM, Dayoub EJ, Herrmann HC, Yeh RW, Groeneveld PW, Doll JA, McCabe JM, Hira RS, Giri J, Fanaroff AC. Association Between 90-Minute Door-to-Balloon Time, Selective Exclusion of Myocardial Infarction Cases, and Access Site Choice: Insights From the Cardiac Care Outcomes Assessment Program (COAP) in Washington State. Circulation. Cardiovascular interventions. 2020 Sep 1; 13(9):e009179.
  20. Doll JA, Hira RS, Kearney KE, Kandzari DE, Riley RF, Marso SP, Grantham JA, Thompson CA, McCabe JM, Karmpaliotis D, Kirtane AJ, Lombardi W. Management of Percutaneous Coronary Intervention Complications: Algorithms From the 2018 and 2019 Seattle Percutaneous Coronary Intervention Complications Conference. Circulation. Cardiovascular interventions. 2020 Jun 12; 13(6):e008962.
  21. Kataruka A, Maynard CC, Kearney KE, Mahmoud A, Bell S, Doll JA, McCabe JM, Bryson C, Gurm HS, Jneid H, Virani SS, Lehr E, Ring ME, Hira RS. Temporal Trends in Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting: Insights From the Washington Cardiac Care Outcomes Assessment Program. Journal of the American Heart Association. 2020 Jun 2; 9(11):e015317.
  22. Doll JA, Kaltenbach LA, Anstrom KJ, Cannon CP, Henry TD, Fonarow GC, Choudhry NK, Fonseca E, Bhalla N, Eudicone JM, Peterson ED, Wang TY. Impact of a Copayment Reduction Intervention on Medication Persistence and Cardiovascular Events in Hospitals With and Without Prior Medication Financial Assistance Programs. Journal of the American Heart Association. 2020 Apr 21; 9(8):e014975.
  23. Hess PL, Kini V, Liu W, Roldan P, Autruong P, Grunwald GK, O'Donnell C, Doll JA, Ho PM, Bradley SM. Appropriateness of Percutaneous Coronary Interventions in Patients With Stable Coronary Artery Disease in US Department of Veterans Affairs Hospitals From 2013 to 2015. JAMA Network Open. 2020 Apr 1; 3(4):e203144.
  24. Morrison J, Plomondon ME, O'Donnell CI, Giri J, Doll JA, Valle JA, Waldo SW. Perceptions of Public and Nonpublic Reporting of Interventional Cardiology Outcomes and Its Impact on Practice: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. Journal of the American Heart Association. 2019 Nov 19; 8(22):e014212.
  25. Doll JA. Quality of life after myocardial infarction: more PROgress needed. Heart (British Cardiac Society). 2020 Jan 1; 106(1):8-9.
  26. Kataruka A, Doll JA, Hira RS. Public Reporting for Cardiac Procedures: Is the Juice Worth the Squeeze? Journal of the American College of Cardiology. 2019 Oct 29; 74(17):2218.
  27. Doll JA, Plomondon ME, Waldo SW. Characteristics of the Quality Improvement Content of Cardiac Catheterization Peer Reviews in the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. JAMA Network Open. 2019 Aug 2; 2(8):e198393.
  28. Rymer JA, Kaltenbach LA, Doll JA, Messenger JC, Peterson ED, Wang TY. Safety of Dual-Antiplatelet Therapy After Myocardial Infarction Among Patients With Chronic Kidney Disease. Journal of the American Heart Association. 2019 May 21; 8(10):e012236.
  29. Doll JA, Jones WS, Lokhnygina Y, Culpepper S, Parks RL, Calhoun C, Au DH, Patel MR. PREPARED Study: A Study of Shared Decision-Making for Coronary Artery Disease. Circulation. Cardiovascular quality and outcomes. 2019 Feb 1; 12(2):e005244.
  30. Doll JA, Hellkamp AS, Thomas L, Fonarow GC, Peterson E, Wang TY. The association of pre- and posthospital medication adherence in myocardial infarction patients. American heart journal. 2019 Feb 1; 208:74-80.
  31. Beatty AL, Doll JA, Schopfer DW, Maynard C, Plomondon ME, Shen H, Whooley MA. Cardiac Rehabilitation Participation and Mortality After Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. Journal of the American Heart Association. 2018 Oct 2; 7(19):e010010.
  32. Wang WT, Hellkamp A, Doll JA, Thomas L, Navar AM, Fonarow GC, Julien HM, Peterson ED, Wang TY. Lipid Testing and Statin Dosing After Acute Myocardial Infarction. Journal of the American Heart Association. 2018 Jan 25; 7(3).
  33. Doll JA, Li S, Chiswell K, Roe MT, Kosiborod M, Scirica BM, Wang TY. Clopidogrel reloading for patients with acute myocardial infarction already on clopidogrel therapy. European heart journal. 2018 Jan 14; 39(3):193-200.
  34. Doll JA, Overton R, Patel MR, Rao SV, Sketch MH, Harrison JK, Tcheng JE. Morbidity and Mortality Conference for Percutaneous Coronary Intervention. Circulation. Cardiovascular quality and outcomes. 2017 Aug 1; 10(8).
  35. Doll JA, Dai D, Roe MT, Messenger JC, Sherwood MW, Prasad A, Mahmud E, Rumsfeld JS, Wang TY, Peterson ED, Rao SV. Assessment of Operator Variability in Risk-Standardized Mortality Following Percutaneous Coronary Intervention: A Report From the NCDR. JACC. Cardiovascular interventions. 2017 Apr 10; 10(7):672-682.
  36. Hess CN, Kaltenbach LA, Doll JA, Cohen DJ, Peterson ED, Wang TY. Race and Sex Differences in Post-Myocardial Infarction Angina Frequency and Risk of 1-Year Unplanned Rehospitalization. Circulation. 2017 Feb 7; 135(6):532-543.
  37. Fanaroff AC, Peterson ED, Chen AY, Thomas L, Doll JA, Fordyce CB, Newby LK, Amsterdam EA, Kosiborod MN, de Lemos JA, Wang TY. Intensive Care Unit Utilization and Mortality Among Medicare Patients Hospitalized With Non-ST-Segment Elevation Myocardial Infarction. JAMA cardiology. 2017 Jan 1; 2(1):36-44.
  38. Doll JA, Hellkamp AS, Goyal A, Sutton NR, Peterson ED, Wang TY. Treatment, Outcomes, and Adherence to Medication Regimens Among Dual Medicare-Medicaid-Eligible Adults With Myocardial Infarction. JAMA cardiology. 2016 Oct 1; 1(7):787-794.
  39. Doll JA, Ohman EM, Patel MR, Milano CA, Rogers JG, Wohns DH, Kapur NK, Rao SV. A team-based approach to patients in cardiogenic shock. Catheterization and Cardiovascular Interventions : Official Journal of The Society For Cardiac Angiography & Interventions. 2016 Sep 1; 88(3):424-33.
  40. Kelly JP, Hammill BG, Doll JA, Felker GM, Heidenreich PA, Bhatt DL, Yancy CW, Fonarow GC, Hernandez AF. The Potential Impact of Expanding Cardiac Rehabilitation in Heart Failure. Journal of the American College of Cardiology. 2016 Aug 30; 68(9):977-8.
  41. Doll JA, Wang TY, Choudhry NK, Cannon CP, Cohen DJ, Fonarow GC, Henry TD, Bhandary DD, Khan N, Davidson-Ray LD, Anstrom K, Peterson ED. Rationale and design of the Affordability and Real-world Antiplatelet Treatment Effectiveness after Myocardial Infarction Study (ARTEMIS): A multicenter, cluster-randomized trial of P2Y12 receptor inhibitor copayment reduction after myocardial infarction. American heart journal. 2016 Jul 1; 177:33-41.
  42. Doll JA, Tang F, Cresci S, Ho PM, Maddox TM, Spertus JA, Wang TY. Change in Angina Symptom Status After Acute Myocardial Infarction and Its Association With Readmission Risk: An Analysis of the Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status (TRIUMPH) Registry. Journal of the American Heart Association. 2016 Jun 13; 5(6).
  43. Doll JA, Neely ML, Roe MT, Armstrong PW, White HD, Prabhakaran D, Winters KJ, Duvvuru S, Sundseth SS, Jakubowski JA, Gurbel PA, Bhatt DL, Ohman EM, Fox KA, TRILOGY ACS Investigators. Impact of CYP2C19 Metabolizer Status on Patients With ACS Treated With Prasugrel Versus Clopidogrel. Journal of the American College of Cardiology. 2016 Mar 1; 67(8):936-47.
  44. Doll JA, Hellkamp A, Thomas L, Ho PM, Kontos MC, Whooley MA, Boyden TF, Peterson ED, Wang TY. Effectiveness of cardiac rehabilitation among older patients after acute myocardial infarction. American heart journal. 2015 Nov 1; 170(5):855-64.
  45. Doll JA, Hellkamp A, Ho PM, Kontos MC, Whooley MA, Peterson ED, Wang TY. Participation in Cardiac Rehabilitation Programs Among Older Patients After Acute Myocardial Infarction. JAMA internal medicine. 2015 Oct 1; 175(10):1700-2.
  46. Doll JA, Sketch MH. ECMO and the Intraaortic Balloon Pump: In Search of the Ideal Mechanical Circulatory Support Device. The Journal of invasive cardiology. 2015 Oct 1; 27(10):459-60.

Questions about the HSR website? Email the Web Team

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.